Fei Lin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Pseudomonas Aeruginosa

Randomized Controlled Trial

Top Venues

SAGE open medicine

International journal of clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Rong He, Fei Lin, Zehui Deng, Bin Yu
Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials. SAGE open medicine 12 (2024)
Rong He, Fei Lin, Zehui Deng, Bin Yu
Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials. SAGE open medicine 12 (2024)
Fei Lin, Bin Yu, Baodong Ling, Guangyao Lv, Huijun Shang, Xia Zhao, Xiaoling Jie, Jing Chen, Yan Li
Weight loss efficiency and safety of tirzepatide: A Systematic review. PloS one 18 (5) (2023)
Fei Lin, Bin Yu, Baodong Ling, Guangyao Lv, Huijun Shang, Xia Zhao, Xiaoling Jie, Jing Chen, Yan Li
Weight loss efficiency and safety of tirzepatide: A Systematic review. PloS one 18 (5) (2023)
Fei Lin, Bin Yu, Baodong Ling, Guangyao Lv, Huijun Shang, Xia Zhao, Xiaoling Jie, Jing Chen, Yan Li
Weight loss efficiency and safety of tirzepatide: A Systematic review. PloS one 18 (5) (2023)
Fei Lin, Qiu'e Yao, Bin Yu, Zehui Deng, Jingyue Qiu, Rong He
The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials. International journal of clinical practice 2023 (2023)
Fei Lin, Bin Yu, Baodong Ling, Guangyao Lv, Huijun Shang, Xia Zhao, Xiaoling Jie, Jing Chen, Yan Li
Weight loss efficiency and safety of tirzepatide: A Systematic review. PloS one 18 (5) (2023)